PJ, May 2020, Vol 304, No 7937

Neurological symptoms common in COVID-19 patients, researchers say

Neurological symptoms are common in patients with COVID-19, particularly if they have a severe infection, research published in JAMA Neurology suggests.…

Deaths: Richard James Bryant

On 13 April 2020, Richard James Bryant MRPharmS, aged 71 years, of Ilford, Essex. Mr Bryant registered with the Society in 1971. …

Myocardial injury associated with increased risk of death from COVID-19, research suggests

The development of myocardial injury in COVID-19 patients is associated with an increased risk of death, researchers have found.…

One in three pharmacists unable to access PPE, finds RPS survey

A third of pharmacists cannot obtain continuous supplies of personal protective equipment, according to a survey conducted by the Royal Pharmaceutical Society.…

Supplies of some COVID-19 medicines to run out within days, government warns

Supplies of certain drugs used when intubating patients with COVID-19 will run out “over the coming days”, the government has warned.…

Tribute: Kouser Chaudry

On 3 April 2020, Kouser Chaudry sadly passed away from terminal breast cancer aged 54 years.  Kouser graduated from John Moores University, Liverpool, and registered with the then Pharmaceutical Society in August 1987. She served in several hospitals, beginning at the Royal Brompton,…

Deaths: Kouser Chaudry

On 3 April 2020, Kouser Chaudry MRPharmS, aged 54 years, of High Wycombe, Buckinghamshire. Mrs Chaudry registered with the Society in 1987. …

Deaths: Janet Luke

On 11 November 2019, Janet Luke MRPharmS, aged 76 years, of Milton Keynes. Mrs Luke registered with the Society in 1964. …

Buprenorphine implant beneficial for patients with opioid dependency

The benefits of delivering buprenorphine by subcutaneous implant, rather than by sublingual tablet, for the treatment of opioid dependence outweigh the risks, research published in BMJ Evidence Based Medicine sugggests…

Pharmacy’s part in COVID-19 response must be recognised

Open access article The Royal Pharmaceutical Society has made this article free to access in order to help healthcare professionals stay informed about an issue of national importance. To learn more about coronavirus, please visit: https://www.rpharms.com/resources/pharmacy-guides…